Clinical Trial Update: Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D [Phase 1]

View source ↗

Summary

ALV-100 is being studied in a Phase 1 trial to assess safety, tolerability, and PK/PD in overweight or obese adults, with or without Type 2 diabetes. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ALV-100

Snippet

Sponsor: Alveus Therapeutics, Inc. | Conditions: Overweight or Obese Adults, Overweight or Obese, Type 2 Diabetes | Phase 1 | Status: RECRUITING